10x Genomics price target lowered to $15 from $20 at Citi
Citi lowered the firm’s price target on 10x Genomics (TXG) to $15 from $20 and keeps a Buy rating on the shares. The firm updated models in the ...
Short Interest in 10x Genomics, Inc. (NASDAQ:TXG) Expands By 34.4%
Genomics, Inc. (NASDAQ:TXG – Get Free Report) was the recipient of a significant growth in short interest in the month of February. As of February 15th, there was short interest totalling 11,320,000 ...
10x Genomics secures injunction against Parse Biosciences’ planned ATAC products
Genomics (TXG) provided an update on its patent litigation with Parse Biosciences. Through a consent agreement entered on February 25, in ...
10x Genomics gets injunction against Parse Biosciences' ATAC Products
Genomics announced that its ATAC-Seq patents were found valid and infringed in its patent litigation with Parse Biosciences.
1 Stock Under $50 on Our Watchlist and 2 to Ignore
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived ...
Charleston Food Truck Festival brings community together through flavor and fun
The Charleston Food Truck Festival returned this weekend to celebrate local cuisine, community, and culture. As Charleston’s ...
National Bank Financial Estimates TSE:TXG FY2025 Earnings
National Bank Financial reduced their FY2025 earnings per share (EPS) estimates for Torex Gold Resources in a note issued to ...
Hosted on MSN2d
The key reason why Liverpool reported a huge loss explained
What were the key reasons behind Liverpool financial losses The club is working to stay competitive while balancing rising ...
Pacific Biosciences: Uncertain Federal Research Funding Latest Blow For Already-Battered Stock
Pacific Biosciences' Q4'24 results missed estimates. Growth in genetic data usage noted, but research funding uncertainties ...